EAM
MDCO

Eagle Asset Management’s Medicines Co MDCO Stock Holding History

Eagle Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-807,720
Closed -$22.1M – 650
2017
Q4 		$22.1M Sell
807,720
-6,714
-0.8% -$207K 0.12% 233
2017
Q3 		$31.1M Sell
814,434
-11,612
-1% -$428K 0.18% 195
2017
Q2 		$31.4M Buy
826,046
+40,062
+5% +$1.78M 0.19% 184
2017
Q1 		$38.4M Sell
785,984
-3,423
-0.4% -$156K 0.24% 134
2016
Q4 		$26.8M Sell
789,407
-174,880
-18% -$6.2M 0.18% 168
2016
Q3 		$36.4M Sell
964,287
-12,824
-1% -$483K 0.25% 129
2016
Q2 		$32.9M Sell
977,111
-112,003
-10% -$3.95M 0.23% 136
2016
Q1 		$34.6M Sell
1,089,114
-24,159
-2% -$789K 0.24% 136
2015
Q4 		$41.6M Sell
1,113,273
-84,573
-7% -$3.2M 0.28% 120
2015
Q3 		$45.5M Buy
+1,197,846
New +$42M 0.31% 107
2014
Q2 		– Sell
-225,733
Closed -$6.42M – 678
2014
Q1 		$6.42M Buy
+225,733
New +$7.47M 0.04% 428

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Eagle Asset Management's MDCO Position: Q1 2018 in Review

Eagle Asset Management sold out of Medicines Co (MDCO) in Q1 2018, closing a stake of 807,720 shares — an estimated $22.1M sold.

Eagle Asset Management first reported a position in MDCO in Q1 2014 and held it in 11 quarters. The position peaked at $45.5M in Q3 2015. 190 funds tracked by Wall St. Rank hold MDCO as of Q1 2018.

  • Eagle Asset Management reported no remaining Medicines Co position as of Q1 2018 after selling out during the quarter.
  • Eagle Asset Management sold 807,720 Medicines Co shares in Q1 2018, an estimated $22.1M.
  • Eagle Asset Management first reported a position in Medicines Co in Q1 2014 and held it in 11 quarters.
  • Eagle Asset Management's Medicines Co position peaked at $45.5M in Q3 2015.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q1 2018.

Based on Eagle Asset Management's 13F filing for Q1 2018, filed 9 May 2018.